← Eichor
Study identifier: NCT06272578 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Screen CardRen - A Cross-sectional Observational Cohort Study

Condition: Heart Failure · Chronic Kidney Diseases  ·  Sponsor: Charite University, Berlin, Germany

PhaseN/A
Planned participants400
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

In this single-centre, cross-sectional study, the investigators aim to assess the prevalence of asymptomatic echocardiographic structural and functional cardiac abnormalities in adult CKD patients with additional cardiovascular risk factors. Furthermore, with the use of Olink technology, analyses of the plasma proteome will be performed to identify potential protein pathways associated with early structural changes.The investigators hypothesize that protein expression will be altered in patients with prevalent echocardiographic abnormalities that indicate stage B heart failure.

This description comes directly from the study's public registry record.

Talk to the study team

Daniela Zurkan  ·  +49 30 450 665 374  ·  daniela.zurkan@dhzc-charite.de

Friederike Fenske  ·  +49 30 450 653 782  ·  friederike.fenske@dhzc-charite.de

Always discuss trial participation with your own doctor first.

Locations (1)

German Heart Center Charité (DHZC)Wedding, State of Berlin, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06272578